通过激活TBC1D311,ZSCAN16可以加速肝细胞癌的进展
Xiaofang Wang1, Bo Xiao2, Fuping Zhong1
1Department of Hepatobiliary Surgery, Pingxiang People's Hospital, Pingxiang, Jiangxi, 337000, P.R. China.
Cell division
|November 8, 2024
概括
指和SCAN域含有蛋白质16 (ZSCAN16) 激活TBC1域家族成员31 (TBC1D31) 转录,促进肝细胞癌 (HCC) 的进展. 抑制ZSCAN16抑制HCC细胞生长和瘤发展.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
背景情况:
- 肝细胞癌 (HCC) 在早期诊断和有效治疗方面存在重大挑战.
- 了解推动HCC进展的分子机制对于开发向疗法至关重要.
研究的目的:
- 研究指和SCAN域含蛋白16 (ZSCAN16) 和TBC1域家族成员31 (TBC1D31) 在HCC.的进展中的功能性作用.
- 阐明ZSCAN16和TBC1D31在HCC中的调控关系.
主要方法:
- 基因表达分析 (RT-qPCR,西斑,免疫组织化学) 用于量化ZSCAN16和TBC1D31水平.
- ChIP-qPCR和双化酶试验证实了ZSCAN16介导的TBC1D31的转录调节.
- 在体外测试 (增殖,迁移,入侵,亡,CCK-8,流细胞计) 和体内异种移植模型,以评估HCC细胞的生物活性和瘤生长.
主要成果:
- 发现ZSCAN16和TBC1D31在HCC组织中表达高.
- 下调ZSCAN16显著抑制HCC细胞的增殖,迁移和入侵,同时促进细胞亡和减少瘤生长体内.
- ZSCAN16直接激活了TBC1D31的转录,而TBC1D31的过度表达可以挽救ZSCAN16的抑制作用,证实ZSCAN16/TBC1D31轴促进HCC.
结论:
- 通过调解TBC1D31.1.的转录激活,ZSCAN16在促进HCC进展方面发挥着至关重要的作用.
- ZSCAN16/TBC1D31轴代表了肝细胞癌的潜在治疗标.
更多相关视频
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
3.5K
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
6.3K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...